Trend analysis of lung cancer incidence rates in Ninawa Province, Iraq, from 2000 to 2010 - Decrease and recent stability

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 1, 2014, Pages 385-390

  Al Hashimi, Muzahem Mohammed Yahya ^a   Wang, Xiang Jun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

decreasing and stable; Incidence; Iraq; Lung cancer; Ninawa; Time trends

Indexed keywords

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; HUMAN; INCIDENCE; INFANT; IRAQ; LUNG TUMOR; MALE; MIDDLE AGED; PRESCHOOL CHILD; REGISTER; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; YOUNG ADULT;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CHILD; CHILD, PRESCHOOL; HUMANS; INCIDENCE; INFANT; IRAQ; LUNG NEOPLASMS; MALE; MIDDLE AGED; REGISTRIES; YOUNG ADULT;

EID: 84894085810     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.1.385     Document Type: Article

References (42)

1. Abbasi S, Badheeb A (2010). Prognostic factors in advanced non-small-cell lung cancer patients: patient characteristics and type of chemotherapy. Lung Cancer Int, 2011, 152125.
2. Al Hasnawi S, Al khuzaie A, Al Mosawi AJ, et al (2009). He Histopathological pattern of lung cancer in Iraq. N Iraqi J Med, 5, 80-3.
3. Al-Madouj, Amal Nasser, Mr. Eldali, et al (2011). Ten year cancer incidence among Nationals of the GCC states 1998-2007, Executive Board Of Health, Ministers' Council For The Gulf, Cooperation Council State, Gulf Center for Cancer Control and Prevention, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
4. American Cancer Society (2013). Cancer facts and figures 2013.
5. Australian Institute of Health and Welfare and Cancer Australia. (2011). Lung cancer in Australia: an overview. Cancer series no. 64. Cat. no. CAN 58. Canberra: AIHW.
6. Canadian Cancer Society's Advisory Committee on Cancer Statistics (2013). Canadian Cancer Statistics 2013. Toronto, ON: Canadian Cancer Society.
7. Cancer Australia (2011). Report to the Nation-Lung Cancer 2011. Cancer Australia, Sydney, NSW.
8. Chen W, Zheng R, Zhang S, et al (2013). The incidences and mortalities of major cancers in China, 2009. Chinese J Cancer, 32, 106-12.
9. Coleman M P, Forman D, Bryant H, et al (2011). Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet, 377, 127-38.
10. D'Addario G, Früh M, Reck M, et al (2010). Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 21, 116-9.
11. Demirci E, Daloglu F, Gundogdu C, et al (2012). Incidence and clinicopathologic features of primary lung cancer: a north-eastern anatolia region study in Turkey (2006-2012). Asian Pac J Cancer Prev, 14, 1989-93.
12. Der S, Navab R, Ishizawa K, Tsao M S (2011). Genomic and Cellular Pathology of Lung Cancer. Current Respiratory Med Rev, 7, 313-322.
13. Directorate of Health in Ninawa MCMEC, (2010). Cancer In Mosul, Incidence and Mortality, Results of Mosul Center Registry; 2000-2010.
14. El-Basmy A, Al-Mohannadi S, Al-Awadi A (2012) Some Epidemiological measures of cancer in Kuwait: National Cancer Registry Data from 2000-2009. Asian Pac J Cancer Prev, 13, 3113-8.
15. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917.
16. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al (2013). Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer, 49, 1374-403.
17. Freedman LS, Edwards BK, Ries LAG, et al (2007). Cancerincidence in four member countries (Cyprus, Egypt, Israel, and Jordan) of the middle east cancer consortium (MECC) compared with US SEER. In: lung cancer: Samir Al Kayed, M. Bassam Kassem. National Cancer Institute. NIH Pub. No. 06-5873. Bethesda, MD.
18. Gonlugur U, Gonlugur TE, Kaptanoglu M, Nadir, A, Cinar Z (2008). The changing epidemiological trends for carcinoma of the lung in Turkey. Saudi Med J, 29, 749.
19. Hayat MJ, Howlader N, Reichman ME, Edwards BK (2007). Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist, 12, 20-37.
20. Hippisley-Cox J, Coupland C (2011). Identifying patients with suspected lung cancer in primary care: derivation and validation of an algorithm. Brit J Gen Pract, 61, 715.
21. Hsu CL, Chen KY, Shih JY, et al (2012). Advanced non-small cell lung cancer in patients aged 45 years or younger: outcomes and prognostic factors. BMC Cancer, 12, 241.
22. Ignatius TS, Tse LA, Qiu H (2012). Occupational Lung Cancer. In A Clinical Guide to Occupational and Environmental Lung Diseases (251-264). Humana Press. International Agency for Research on Cancer, lung cancer statistics (2008).
23. Iraqi Cancer Board (2010). Results of the Iraqi Cancer Registry 2010. Baghdad, Iraqi Cancer Registry Center, Ministry of Health.
24. Jemal A, Siegel R, Ward E, et al, (2009). Cancer statistics. CA Cancer J Clin, 59, 225-49.
25. Jemal A, Siegel R, Xu J, Ward E (2010). Cancer statistics. CA Cancer J Clin, 60, 277-300.
26. Johnson F, Johnson FW (2009). Arrowhead Ripper: Adaptive Leadership in Full Spectrum Operations. Strategic Studies Institute.
27. Khuder SA (2001). Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis. Lung Cancer, 31, 139-48.
28. Ma HT, Sriyam S, Sinchaikul S, Tsai H Y, Phutrakul S (2013). Proteomics Characterization of Haptoglobin Alpha-2 Subunit in Non-Small Cell Lung Cancer Serum and Various Human Materials. J Proteomics Bioinform, 6, 187-96.
29. Mehrabani D, Tabei SZ, Heydari ST, et al (2008). Cancer occurrence in Fars Province, Southern Iran. Iranian Red Crescent Med J, 10, 314-22.
30. Ministry of Planning, Central Organization for Statistics. (2012). Annual Abstract of Statistics, 2000-2009. Baghdad, Iraq.
31. Missaoui N, Hmissa S, Landolsi H, et al (2011). Lung cancer in central Tunisia: epidemiology and clinicopathological features. Asian Pac J Cancer Prev, 12, 2305-9.
32. Perez-Moreno P, Brambilla E, Thomas R, Soria J C (2012). Squamous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities. Clin Cancer Res, 18, 2443-2451.
33. Ramalingam SS, Owonikoko TK, Khuri FR (2011). Lung cancer: new biological insights and recent therapeutic advances. CA: A Cancer J Clin, 61, 91-112.
34. Salim EI, Jazieh AR, Moore MA (2011). Lung cancer incidence in the Arab league countries: Risk factors and control. Asian Pac J Cancer Prev, 12, 17-34.
35. Sadraei NH, Taghi Riahi MD (2013). Idiopathic pulmonary fibrosis in a referral center in Iran: Are patients developing the disease at a younger age? Arch Iranian Med, 16, 177.
36. SEER (2013). SEER Stat Fact Sheets: Lung and Bronchus
37. Tarawneh M, Nimri O, Arkoob K, Zaghal M A (2009). Cancer Incidence in Jordan 2009. Non-Communicable Diseases Directorate, Jordan Cancer Registry. Ministry of Health.
38. Tarrahi MJ, Mehrabani D, Khademolhosseini F, et al (2009). Lung cancer occurrence in Southern Iran. J Res Med Sci, 14, 139-40.
39. Tas F, Keskin S (2012). Age-specific incidence ratios of lung cancer (LC) in Turkey: LC in older people is increasing. Arch Gerontol Geriatrics, 55, 276-8.
40. Tazi MA, Er-Raki A, Benjaafar N (2013). Cancer incidence in Rabat, Morocco: 2006-2008. E Cancer Med Sci, 7, 338.
41. Yousefi-Koma A, Panah-Moghaddam M, Kalff V (2013). The utility of metabolic imaging by 18F-FDG PET/CT in lung cancer: impact on diagnosis and staging. TANAFFOS-J Respiratory Disease, Thoracic Surgery, Intensive Care and Tuberculosis, 12, 16-25.
42. Zeng H, Zheng R, Zhang S, He J, Chen W (2013). Lung cancer incidence and mortality in China, 2008. Thoracic Cancer, 4, 53-8.